CVE-2019-10068
Published: March 25, 2022
Official Description
Kentico contains a failure to validate security headers. This deserialization can led to unauthenticated remote code execution.
CISA KEV Advisory
Kentico Xperience Deserialization of Untrusted Data Vulnerability
Kentico contains a failure to validate security headers. This deserialization can led to unauthenticated remote code execution.
Apply updates per vendor instructions.
Risk Analysis
This Kentico vulnerability involves a failure to properly validate security headers, leading to a deserialization flaw that can result in unauthenticated remote code execution. With an EPSS score of 0.93889, exploitation is highly probable, and its presence in CISA's KEV confirms active exploitation, making it a critical vulnerability.
This vulnerability is actively being exploited in the wild, as confirmed by its 'in_the_wild' exploit status and inclusion in CISA's KEV. Exploitation does not require authentication, making it remotely exploitable.
Organizations using Kentico should apply all available security updates and patches immediately. Reviewing and hardening security configurations related to header validation and deserialization is also advised.
Technical Analysis
CVE-2019-10068 requires local access, meaning attackers must already have a foothold on the target system.
Exploitation requires some privileges, which limits the exposure to scenarios where an attacker has already gained initial access.
CISA has added CVE-2019-10068 to the Known Exploited Vulnerabilities (KEV) catalog, confirming active exploitation in the wild. U.S. federal agencies are required to patch this within the mandated timeframe, and all organizations should treat remediation as urgent.
Exploit & PoC Resources
All References (1)
Quick Facts
Recommended Actions
- →Apply vendor patches immediately
- →Monitor CVE-2019-10068 in threat intel feeds
- →Review IDS/IPS signatures for exploitation attempts
- !CISA KEV: Federal agencies must patch per BOD 22-01 timeline
- !Active exploitation confirmed — treat as P1